Sidebar Post - Cost Curve News

Latest Posts

Lilly Expands Its Pharm-to-Table Offering, Promotes a Lower Price for Consistent Use

Regulating DTC Is All the Rage, Suddenly. But It Turns Out that Americans Do Want to Hear from Brands

Vaccine Politics and Policy Have Gone Off the Rails. Let’s Hope Reimbursement Stays on Track

There Has Been a Small Deluge of MFN News Over the Past 24 Hours, But Does It Matter?

A Parade of Pharma Execs Have Been Asked About MFN This Week, and the Commentary Is (Unintentionally) Revealing

Popular

Lilly Expands Its Pharm-to-Table Offering, Promotes a Lower Price for Consistent Use

Regulating DTC Is All the Rage, Suddenly. But It Turns Out that Americans Do Want to Hear from Brands

Vaccine Politics and Policy Have Gone Off the Rails. Let’s Hope Reimbursement Stays on Track

There Has Been a Small Deluge of MFN News Over the Past 24 Hours, But Does It Matter?

A Parade of Pharma Execs Have Been Asked About MFN This Week, and the Commentary Is (Unintentionally) Revealing

MFN ‘Conversations’ Have Started, Pfizer’s Bourla Says, But There’s Not Much There There

Most Viewed

CMS Patient-Focused Listening Session Transcripts (2,125)
Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,334)
More IRA Lawsuits Coming, PhRMA Chief Predicts (1,099)
Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,085)
Looking Under the Hood at the Pricing Approach for the New Zepbound Obesity Med (1,031)

Home
About
News
Subscribe